CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial.

Autor: Viglietta V, Bourcier K, Buckle GJ, Healy B, Weiner HL, Hafler DA, Egorova S, Guttmann CR, Rusche JR, Khoury SJ
Zdroj: Neurology; 9/16/2008, Vol. 71 Issue 12, p917-924, 8p
Databáze: Supplemental Index